Refine by
Oligomerix Clinical Program Equipment & Supplies
2 equipment items found
by:Oligomerix, Inc. based inWhite Plains, NEW YORK (USA)
While Alzheimer’s is the largest tauopathy, other tauopathies are rare diseases that present accelerated regulatory pathways and significant near-term commercial opportunities. These rare diseases shown in Chart A below have a tau etiology similar to AD. Oligomerix’s 1st clinical program focuses on demonstrating safety and efficacy of our lead ...
by:Oligomerix, Inc. based inWhite Plains, NEW YORK (USA)
Our lead compound, known as OLX07010, is a small molecule inhibitor of tau self-association which has demonstrated in vivo efficacy in two transgenic mouse models of tauopathy, htau and JNPL3, representing tau aggregation in AD and inherited tauopathies, respectively. ...